ArticleBMC cancer2020

A novel TGF-β receptor II mutation (I227T/N236D) promotes aggressive phenotype of oral squamous cell carcinoma via enhanced EGFR signaling.

Hwa-Kyung Son et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.